Baxter International
As on 02 Jul, 2025 | 01:29 IST
| Open | 30.11 |
| Previous Close | 30.28 |
| Beta | 0.70 |
| High | 31.76 |
| Low | 30.06 |
| TTM EPS See historical trend | 2.61(-5.43% YoY) |
| 52 Week High | 40.42 |
| 52 Week Low | 26.26 |
| TTM PE See historical trend | 11.96(Average PE) |
| Mkt. Cap ($ Billion) | 15.93 |
| Dividend Yield | 1.99 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 30.62 |
| 10 | 30.36 |
| 20 | 30.54 |
| 50 | 30.55 |
| 100 | 31.56 |
| 200 | 32.8 |
Returns
| 1 Week | 4.01% | |
| 1 Month | 2.29% | |
| 3 Months | -7.54% | |
| YTD | 7.08% | |
| 1 Year | -6.71% | |
| 3 Years | -51.39% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 186.95 | -1.76 | 450.39 | 18.01 | 10.38 | 2.83 | 194.47/141.30 | 4.01 | Very Bullish |
| Abbott | 126.61 | -0.45 | 219.60 | 25.37 | 4.99 | 1.76 | 141.07/110.89 | -5.20 | Very Bearish |
| Intuitive Surgical | 545.54 | -1.04 | 193.27 | 63.33 | 8.61 | -- | 614.58/427.84 | 23.62 | Very Bearish |
| Boston Scientific | 100.97 | -1.43 | 154.38 | 38.80 | 2.70 | -- | 107.53/72.01 | -0.44 | Very Bullish |
| Stryker | 375.87 | -2.05 | 143.00 | 29.25 | 12.85 | 0.84 | 404.81/330.36 | 1.85 | Neutral |
Market news
- Wall St ends sharply higher as earnings optimism fuels risk appetiteOctober 21, 2025 8:00 AM
- Wall Street ends higher as investors digest Trump trade commentsOctober 18, 2025 8:37 AM
- Wall Street sells off as Trump hits China with more tariffsOctober 11, 2025 8:32 AM
- Dow, S&P 500 manage record closing highs; Nasdaq falls in volatile sessionOctober 4, 2025 9:34 AM
About the company
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.